Endonovo Therapeutics, Inc. (ENDV) stock
ENDVOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2023, quarter ended Sep 30, 2023Last filing: 10-Q/A on Dec 29, 2023
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $135.08KP/E –Yield –
Endonovo Therapeutics statistics
33 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Dec 31, 2022
- Share price as of
- –
Share statisticsIndustry
- Shares Change (YoY)
- 132.6%
- 3.32%
- Float
- 319M
- 37M
- Shares Held by Insiders
- 0.00%
- 10.5%
MarginsIndustry
- Pretax Margin
- -13649.2%
- -2.32%
- EBITDA Margin
- -1933.7%
- -2.52%
Returns on capitalIndustry
- Return on Assets (ROA)
- -1123.6%
- -12.3%
Financial positionIndustry
- Current Ratio
- 0.00
- 2.49
- Quick Ratio
- 0.00
- 1.53
GrowthIndustry
- Revenue Growth (YoY)
- 85.2%
- 9.42%
- Revenue Growth (3Y CAGR)
- -24.1%
- 7.08%
EfficiencyIndustry
- Asset Turnover
- 0.08
- 0.59
- Revenue Per Employee
- $135.36K
- $331.99K
- Profits Per Employee
- -$18.47M
- -$46.47K
- Employee Count
- 1
- 193
Income statement (TTM)Industry
- Pretax Income
- -$18.47M
- -$1.83M
Balance sheetIndustry
- Net Cash (Debt)
- $98
- $3.95M
- Net Cash Per Share
- $0.00
- $0.26
- Equity (Book Value)
- -$32.18M
- $63.80M
- Book Value Per Share
- -$0.10
- $3.26
- Tangible Book Value
- -$33.45M
- $11.61M
- Working Capital
- -$33.37M
- $57.32M
Cash flow (TTM)Industry
Scores and fair valueIndustry
- Piotroski F-Score
- 4
- 5
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | ENDV | S&P 500 | Difference | ENDV per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | 0.0% | +0.6% | −0.6 pts | ||
| 3 months | 0.0% | +3.4% | −3.4 pts | ||
| Year to date | 0.0% | +13.3% | −13.3 pts | ||
| 1 year | 0.0% | +16.6% | −16.6 pts | ||
| 3 years | -99.3% | +86.4% | −185.7 pts | -80.7% | +23.1% |
| 5 years | -99.6% | +81.9% | −181.5 pts | -66.9% | +12.7% |
| 10 years | -100.0% | +318.9% | −418.9 pts | -75.3% | +15.4% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Aug 29, 2025.
1M ENDV shares were sold short on Aug 29, 2025, up 0.0% from the previous report. At recent volumes it would take 1.0 days to buy them back.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Aug 29, 2025 | 518,992 | +0.0% | 91,283,226 | 1.0 |
| Aug 15, 2025 | 518,991 | -0.0% | 24,549,607 | 1.0 |
| Jul 31, 2025 | 519,081 | -13.4% | 24,987,575 | 1.0 |
| Jul 15, 2025 | 599,075 | -1.6% | 1,358,808 | 1.0 |
| Jun 30, 2025 | 608,979 | -1.6% | 4,541,936 | 1.0 |
| Jun 13, 2025 | 618,960 | 0.0% | 24,602,593 | 1.0 |
| May 30, 2025 | 618,960 | -0.0% | 6,696,662 | 1.0 |
| May 15, 2025 | 618,967 | -0.0% | 3,311,367 | 1.0 |
| Apr 30, 2025 | 618,979 | 0.0% | 12,508,006 | 1.0 |
| Apr 15, 2025 | 618,979 | 0.0% | 40,682,158 | 1.0 |
| Mar 31, 2025 | 618,979 | +54.7% | 86,162,058 | 1.0 |
| Mar 14, 2025 | 400,000 | +300.0% | 23,757,632 | 1.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?